Table 4.
Net reclassification improvement based on addition of gene count score to Cambridge risk score
| Predicted diabetes risk (Cambridge risk score) | No of people | Reclassified | Net correctly reclassified (%) | |||||
|---|---|---|---|---|---|---|---|---|
| <5% | 5-10% | 10-15% | >15% | Increased risk | Decreased risk | |||
| Plus gene count score—people without diabetes during follow-up (n=3324) | ||||||||
| <5% | 2088 | 105 | 0 | 0 | 167 | 131 | −1.1 | |
| 5-9.9% | 75 | 581 | 43 | 0 | ||||
| 10-14.9% | 0 | 42 | 219 | 19 | ||||
| ≥15% | 0 | 0 | 14 | 138 | ||||
| Plus gene count score—people with diabetes during follow-up (n=202) | ||||||||
| <5% | 60 | 4 | 0 | 0 | 12 | 12 | 0 | |
| 5-9.9% | 3 | 49 | 2 | 0 | ||||
| 10-14.9% | 0 | 6 | 36 | 6 | ||||
| ≥15% | 0 | 0 | 3 | 33 | ||||
Net reclassification improvement −1.1% (95% CI −6.0% to 3.8%); P=0.66.